Pharmacokinetics of Afamelanotide in EPP Patients
Phase 1
Completed
- Conditions
- Erythropoietic Protoporphyria
- Interventions
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Clinuvel Europe Limited
- Target Recruit Count
- 28
- Registration Number
- NCT06388642
- Locations
- 🇳🇱
CLINUVEL Site, Rotterdam, Netherlands
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V
- First Posted Date
- 2022-05-11
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Clinuvel Europe Limited
- Target Recruit Count
- 6
- Registration Number
- NCT05370235
- Locations
- 🇪🇸
CLINUVEL Investigational site, Clinuvel Investigational Site, Spain
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Clinuvel Europe Limited
- Target Recruit Count
- 6
- Registration Number
- NCT05159752
- Locations
- 🇩🇪
CLINUVEL investigative site, Regensburg, Germany
© Copyright 2025. All Rights Reserved by MedPath